Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • When Immigrant Parents Are Arrested
  • Sandwiched Caregivers
  • Medical Debt
  • Rising Health Costs
  • Ivermectin Sales

WHAT'S NEW

  • When Immigrant Parents Are Arrested
  • Sandwiched Caregivers
  • Medical Debt
  • Rising Health Costs
  • Ivermectin Sales

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jun 8 2017

Full Issue

A Lonely Fight: This Republican Has Ideas On NIH Spending, But Not Many Like-Minded Allies

Rep. Andy Harris (R-Md.) wants to shake up the agency by cutting indirect costs and using the savings to fund thousands of research projects instead. Meanwhile, scientists are wary of proposed federal funding caps for grants to individual labs.

Stat: In Congress, Former Scientist Wants To Change How The NIH Does Business

[Rep. Andy] Harris is without question uniquely knowledgeable on NIH issues. He is a former Johns Hopkins research physician whose work the agency funded for a decade. One study, on the “cerebrovascular effects of intravenous dopamine infusions in fetal sheep,” is published in the Journal of Applied Physiology. He has also kept a close eye on the federal government’s research arm. But in the months following President Trump’s inauguration, he has pursued what is perhaps an unexpected mission given his background: changing the way the NIH spends its money. (Facher, 6/8)

Boston Globe: Local Scientists Worry About NIH’s Proposed Cap On Funding For Individual Labs 

Doug Melton, one of the nation’s top stem cell scientists, juggles research and other programs at his Harvard University lab, which is funded by a half-dozen grants from the National Institutes of Health — the federal agency that has long been the engine for US biomedical research. But like other senior scientists in the Boston area, he stands to lose some of that funding under a proposed NIH cap on the number of grants it awards to individual labs. (Weisman, 6/7)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Thursday, June 18
  • Wednesday, June 17
  • Tuesday, June 16
  • Monday, June 15
  • Friday, June 12
  • Thursday, June 11
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF